Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.85p
   
  • Change Today:
      0.20p
  • 52 Week High: 7.35
  • 52 Week Low: 2.40
  • Currency: UK Pounds
  • Shares Issued: 697.20m
  • Volume: 1,541,272
  • Market Cap: £26.84m

Poolbeg Pharma Overview

Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which the Directors believe enables it to develop multiple products faster and more cost effectively than the traditional biotech model. Poolbeg has aspirations to become the “one-stop shop” for Big Pharma seeking mid-stage products to license or acquire.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE 2.0%  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 2.9  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Poolbeg Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 n/a (2.34) (0.74)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (4.78) (0.94)p n/a n/a n/a n/a 0.0%
31-Dec-23 n/a (3.93) (0.79)p n/a n/a n/a n/a 0.0%
31-Dec-24 n/a (5.79) (1.16)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Poolbeg Pharma Company Announcements

POLB 001 European Patent granted 20-Nov-2025 07:00 RNS
Interim Results for the six months to 30 June 2025 29-Sep-2025 07:00 RNS
POLB 001 Phase 2a Trial Update 25-Sep-2025 07:00 RNS

Poolbeg Pharma ShareCast News

Director dealings: Poolbeg Pharma co-founder rai... 25-Jun-2025 ShareCast
Poolbeg Pharma extends cash runway after raising... 23-May-2025 ShareCast
Poolbeg raises nearly £5m to progress clinical t... 20-May-2025 ShareCast

Latest Poolbeg Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 3.85p
Change Today 0.20p
% Change 5.48 %
52 Week High 7.35
52 Week Low 2.40
Volume 1,541,272
Shares Issued 697.20m
Market Cap £26.84m

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average
7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average
Price Trend
87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average
77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 08-Dec-2025

Time Volume / Share Price
16:24 50,000 @ 4.05p
14:52 10,000 @ 4.05p
14:38 49,700 @ 4.03p
12:55 2,360 @ 4.03p
12:52 2,509 @ 4.03p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page